Overview
The USDA recently issued its Interim Final Rule on U.S. hemp production. The FDA continues to delay action on its development of a formal regulatory regime for hemp-derived CBD. Jonathan Miller, the industry’s lead national lobbyist, shares his unique insight on the regulatory path forward for hemp and CBD.
This video was created for general informational purposes only as of the time of its creation and does not constitute legal advice, the formation of an attorney client relationship, or a solicitation to provide legal services.
Note: This webinar is part of a monthly series in which Frost Brown Todd attorneys focus on hemp-related topics and trends through the lens of various legal disciplines, from general regulatory to intellectual property, banking, and advertising law. For updates, visit www.hemplegallyspeaking.com.